http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Self-healing Corrosion Protective Coating Using Nanofibers for Controlled Release of Inhibitor
Yusuke Takimoto,Ji Ha Lee,Akihiro Yabuki 한국고분자학회 2021 한국고분자학회 학술대회 연구논문 초록집 Vol.46 No.2
In general, the technique to prevent corrosion and corrosion protection is to coat a polymer on the carbon plate. We previously have developed a coating technique that effectively releases corrosion inhibitors by adding the Cellulose nanofibers (CNFs) in the polymer coating. This system have shown the high self-healing properties. In this research, we introduce the coating method which was prepared CNFs at different temperatures to effectively release the corrosion inhibitor.
Suzuki, Nobutaka,Takimoto, Yuko,Suzuki, Riho,Arai, Takanari,Uebaba, Kazuo,Nakai, Masuo,Strong, Jeffry Michael,Tokuda, Harukuni Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.6
Extract of Lentinula edodes mycelia (LEM) is currently utilized as an oral biological response modifier (BRM) medicine for cancer patients. However, its effectiveness for breast cancer patients with postoperative adjuvant hormone therapy has not yet been scientifically verified. In this study, we investigated the influence of LEM on the quality of life (QOL) and immune response in breast cancer patients undergoing postoperative adjuvant hormone therapy. Twenty patients were studied in total. They received only hormone therapy in the first 4 weeks followed by hormone therapy and LEM during the next 8 weeks. Laboratory tests, QOL score and peripheral blood cytokine production levels were evaluated during the study period. No changes in QOL or cytokines were noted after the first 4 weeks. In contrast, during the following combined therapy period, improvements were noted in QOL and cytokine levels. Although a future large-scale investigation is necessary to confirm these results, these data suggest that the concomitant use of LEM with postoperative adjuvant hormone therapy improves the QOL and immune function of patients.